Jewett, Anahid. 2025. “First in Human Clinical Study Demonstrating the Safety and Efficacy of NK101 (supercharged NK Cells) in the Treatment of Patients With Cancer”. South East European Journal of Immunology 8 (CITIM):040. https://doi.org/10.3889/seejim.2025.6102.